ArticleJournal of enzyme inhibition and medicinal chemistry2021

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.

Mohammed M Alanazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.